Clinical experience of tocilizumab treatment among a cohort of patients with COVID-19 infection from Western India

BACKGROUND: Initiation of tocilizumab (TCZ) treatment in patients with coronavirus disease 2019 (COVID-19) during the early phases of cytokine storm is crucial. This study evaluated the clinical experience of TCZ use in the treatment of patients with COVID-19. METHODS: This retrospective observation...

Descripción completa

Detalles Bibliográficos
Autores principales: Surana, Prince D., Nayak, Rupesh, Sheikh, Arif, Haldankar, Pradnya, Kale, Jyoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930122/
https://www.ncbi.nlm.nih.gov/pubmed/35309657
http://dx.doi.org/10.4103/jfmpc.jfmpc_817_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930122/
https://www.ncbi.nlm.nih.gov/pubmed/35309657
http://dx.doi.org/10.4103/jfmpc.jfmpc_817_21

Ejemplares similares